Cameron Turtle - Insider Trading & Ownership

Entity
Individual
Location
C/O Eidos Therapeutics, Inc., 101 Montgomery Street, Suite 2550, San Francisco, CA
Summary
The estimated net worth of Cameron Turtle is at least $673K dollars as of September 6, 2024. Cameron Turtle is the Chief Executive Officer, Director of Spyre Therapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (SYRE) stock worth about $419K. Cameron Turtle is the Director of Oruka Therapeutics, Inc. and owns shares of Oruka Therapeutics, Inc. (ORKA) stock worth about $254K.
All Insider Reports
All Insider Reports

Ownership of Cameron Turtle

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SYRE Spyre Therapeutics, Inc. Chief Executive Officer, Director $419K Feb 15, 2024
ORKA, ABIO Oruka Therapeutics, Inc. Director $254K Aug 29, 2024

Insider Transactions Reported by Cameron Turtle:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.